tiprankstipranks
Advertisement
Advertisement

RGEN Stock Latest News

Repligen Shareholders Approve Directors, Auditor and Pay Plan
Company AnnouncementsRepligen Shareholders Approve Directors, Auditor and Pay Plan
17d ago
8K
RGEN
Repligen resumed with an Outperform at RBC Capital
PremiumThe Fly
Repligen resumed with an Outperform at RBC Capital
18d ago
RGEN
Repligen price target raised to $160 from $145 at Barclays
PremiumThe Fly
Repligen price target raised to $160 from $145 at Barclays
25d ago
RGEN
Repligen price target lowered to $165 from $180 at JPMorgan
PremiumThe Fly
Repligen price target lowered to $165 from $180 at JPMorgan
26d ago
RGEN
Repligen Earnings Call Highlights Growth, Margin Momentum
PremiumCompany Announcements
Repligen Earnings Call Highlights Growth, Margin Momentum
27d ago
RGEN
Repligen price target lowered to $142 from $152 at Jefferies
PremiumThe FlyRepligen price target lowered to $142 from $152 at Jefferies
27d ago
RGEN
Repligen raises FY26 EPS view to $1.97-$2.05 from $1.93-$2.10, consensus $1.97
Premium
The Fly
Repligen raises FY26 EPS view to $1.97-$2.05 from $1.93-$2.10, consensus $1.97
27d ago
RGEN
Repligen reports Q1 adjusted EPS 48c, consensus 38c
Premium
The Fly
Repligen reports Q1 adjusted EPS 48c, consensus 38c
27d ago
RGEN
RGEN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RGEN Upcoming Earnings Report: What to Expect?
29d ago
RGEN
Repligen price target lowered to $145 from $165 at Canaccord
PremiumThe Fly
Repligen price target lowered to $145 from $165 at Canaccord
1M ago
RGEN
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
2M ago
SR
CLX
Repligen opens new Training & Innovation Center in Netherlands
PremiumThe Fly
Repligen opens new Training & Innovation Center in Netherlands
2M ago
RGEN
Repligen initiated with a Buy at Rothschild & Co Redburn
PremiumThe FlyRepligen initiated with a Buy at Rothschild & Co Redburn
2M ago
RGEN
Repligen price target lowered to $145 from $175 at Barclays
Premium
The Fly
Repligen price target lowered to $145 from $175 at Barclays
2M ago
RGEN
Repligen price target lowered to $140 from $170 at Evercore ISI
Premium
The Fly
Repligen price target lowered to $140 from $170 at Evercore ISI
2M ago
RGEN
Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
PremiumRatings
Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
2M ago
RGEN
Repligen price target raised to $208 from $180 at H.C. Wainwright
PremiumThe Fly
Repligen price target raised to $208 from $180 at H.C. Wainwright
2M ago
RGEN
Repligen price target lowered to $195 from $200 at UBS
PremiumThe Fly
Repligen price target lowered to $195 from $200 at UBS
3M ago
RGEN
Repligen price target lowered to $170 from $180 at Evercore ISI
PremiumThe Fly
Repligen price target lowered to $170 from $180 at Evercore ISI
3M ago
RGEN
Repligen: Solid Execution and Credible Growth Outlook, But Upside Limited at Current Valuation
PremiumRatingsRepligen: Solid Execution and Credible Growth Outlook, But Upside Limited at Current Valuation
3M ago
RGEN
Repligen price target lowered to $180 from $190 at Wells Fargo
Premium
The Fly
Repligen price target lowered to $180 from $190 at Wells Fargo
3M ago
RGEN
Repligen price target lowered to $175 from $200 at Barclays
Premium
The Fly
Repligen price target lowered to $175 from $200 at Barclays
3M ago
RGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >